Leffall, one of five surgeons to serve as president of two ACSs, the American Cancer Society and American College of Surgeons

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

We have known a giant—physically, mentally, fraternally, socially, professionally, ethically, spiritually. Now he is gone, but will be long remembered and loved.

Growing up as the son of educators in the segregated South, LaSalle Leffall was taught that education and character were key, and he learned that lesson well. He pursued excellence successfully in so many arenas, and his character was never questioned. This pursuit of excellence led him to become a physician, a surgeon, an oncologist, and a consistent, tenacious leader.

Being first became commonplace for him: the first African American president of the American Cancer Society (1994-1995), the first African American member of the Southern Surgical Association, the first African American president of the American College of Surgeons (2009-2010), one of five surgeons to serve as president of the two ACSs—and more, are among his many accomplishments.

A master orator with the memory of an elephant, LaSalle would hold his audience spellbound as he told stories, used extensive quotations, and made emphatic points, all without notes or prompters. Driven always by principle—never blustery, always emphatic—he would successfully sway opinion in his ongoing effort to right longstanding wrongs and to enhance understanding. His knowledge and ability in surgery, oncology, and health policy was prolific. He was ever-responsive. His counsel was in wide demand, even to some presidents of our nation.

Dr. LaSalle Leffall in O.R, #3
LaSalle D. Leffall, Jr. as a young surgeon in the 1960s. – Photo courtesy of Howard University Archives

He was a devoted family man, and he and Ruthie were an ever present and enviable team, like salt and pepper.

LaSalle was a charismatic leader during a time of sea change in our nation. So often it seems to occur in our good land and accrues to our general benefit—the right man at the right time.

He had friends in all spheres of influence and activity, including some of the giants of jazz. They taught him the importance of the “grace note.” It is with a grace note that he has left us.

Thank you, my old and true friend.


The author is an adjunct professor of surgery at Emory University School of Medicine.

LaMar S. McGinnis
Adjunct professor of surgery, Emory University School of Medicine

YOU MAY BE INTERESTED IN

At the Sept. 4 meeting of the National Cancer Advisory Board, NCI Principal Deputy Director Douglas R. Lowy provided an overview of how NCI is weathering the maelstrom of executive orders, policy changes, and funding uncertainties that has come down on federal agencies and research institutes since Donald Trump’s inauguration in January. 
A Senate hearing that the administration hoped would be a routine check-in on the president’s 2026 MAHA-driven healthcare agenda erupted into a political firestorm as senators jumped at their first opportunity to confront HHS Secretary Robert F. Kennedy Jr. over the chaos engulfing the Centers for Disease Control and Prevention.
In December 1971, President Richard Nixon signed the National Cancer Act and declared a “War on Cancer.” In the past 54 years, the U.S. has invested $180 billion nominally, or approximately $322 billion when adjusted for inflation, in cancer research. This investment has paid dividends with more than 100 anticancer drugs brought to market in half a century—virtually all traceable to National Cancer Institute funding. 
LaMar S. McGinnis
Adjunct professor of surgery, Emory University School of Medicine

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login